The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases

Acta Pharmacologica Sinica

Volumn 36, Issue 1, 2015, Pages 51-61

  Audet Walsh, Étienne ^a   Giguére, Vincent ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

diabetes; energy metabolism; fatty liver; glucose; metabolic syndrome; mitochondria; nuclear receptors; oxidative phosphorylation; skeletal muscle

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; ERRALPHA ESTROGEN-RELATED RECEPTOR; LIGAND;

AEROBIC METABOLISM; BROWN ADIPOSE TISSUE; CANCER CELL; CARBOHYDRATE METABOLISM; CELL ENERGY; CELL METABOLISM; CITRIC ACID CYCLE; ENERGY METABOLISM; ESTROGEN RESPONSIVE ELEMENT; FATTY ACID OXIDATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; METABOLIC DISORDER; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; RESPIRATORY CHAIN; REVIEW; SKELETAL MUSCLE; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HOMEOSTASIS; HUMANS; LIGANDS; METABOLIC DISEASES; RECEPTORS, ESTROGEN;

EID: 84920371205     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2014.121     Document Type: Review

References (96)

1. Evans RM, Mangelsdorf DJ. Nuclear receptors, RXR, and the Big Bang. Cell 2014; 157: 255-66.
2. Green S, Walter P, Kumar V, Krust A, Bornet JM, Argos P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erbA. Nature (London) 1986; 320: 134-39.
3. Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150-54.
4. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature (London) 1985; 318: 635-41.
5. Giguère V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature 1988; 331: 91-94.
6. Giguère V. To ERR in the estrogen pathway. Trends Endocrinol Metab 2002; 13: 220-25.
7. Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008; 29: 677-96.
8. Deblois G, Giguère V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim Biophys Acta 2011; 1812: 1032-40.
9. Tremblay AM, Giguère V. The NR3B subgroup: an ovERRview. Nucl Recept Signal 2007; 5: e009.
10. Villena JA, Kralli A. ERRα: a metabolic function for the oldest orphan. Trends Endocrinol Metab 2008; 19: 269-76.
11. Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, et al. Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity. Cancer Res 2009; 69: 6149-57.
12. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol 2006; 20: 1707-14.
13. Deblois G, Chahrour G, Perry MC, Sylvain-Drolet G, Muller WJ, Giguère V. Transcriptional control of the ERBB2 amplicon by ERRα and PGC-1β promotes mammary gland tumorigenesis. Cancer Res 2010; 70: 10277-87.
14. Deblois G, Giguere V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer 2013; 13: 27-36.
15. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009; 462: 58-64.
16. Charest-Marcotte A, Dufour CR, Wilson BJ, Tremblay AM, Eichner LJ, Arlow DH, et al. The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions. Genes Dev 2010; 24: 537-42.
17. Chaveroux C, Eichner LJ, Dufour CR, Shatnawi A, Khoutorsky A, Bourque G, et al. Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced non-alcoholic fatty liver. Cell Metab 2013; 17: 586-98.
18. Dufour CR, Levasseur MP, Pham NHH, Eichner LJ, Wilson BJ, Charest-Marcotte A, et al. Genomic convergence among ERRα, Prox1, and Bmal1 in the control of metabolic clock outputs. PLoS Genet 2011; 7: e1002143.
19. Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, Takahashi N, et al. PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA 2003; 100: 12378-83.
20. Gaillard S, Dwyer MA, McDonnell DP. Definition of the molecular basis for estrogen receptor-related receptor-α-cofactor interactions. Mol Endocrinol 2007; 21: 62-76.
21. Gaillard S, Grasfeder LL, Haeffele CL, Lobenhofer EK, Chu TM, Wolfinger R, et al. Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Mol Cell 2006; 24: 797-803.
22. Schreiber SN, Emter R, Hock MB, Knutti D, Cardenas J, Podvinec M, et al. The estrogen-related receptor alpha (ERRα) functions in PPARγ coactivator 1α (PGC-1α)-induced mitochondrial biogenesis. Proc Natl Acad Sci USA 2004; 101: 6472-7.
23. Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor ERRα. J Biol Chem 2003; 278: 9013-8.
24. McGuirk S, Gravel SP, Deblois G, Papadopoli DJ, Faubert B, Wegner A, et al. PGC-1α supports glutamine metabolism in brreast cancer cells. Cancer Metab 2013; 1: 22.
25. Eichner LJ, Giguère V. Estrogen-related receptors (ERRs): a new dawn in the control of mitochondrial gene networks. Mitochondrion 2011; 11: 544-52.
26. Cai Q, Lin T, Kamarajugadda S, Lu J. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 2013; 32: 2079-86.
27. Eichner LJ, Perry M-C, Dufour CR, Bertos N, Park M, St-Pierre J, et al. mir-378∗ mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metab 2010; 12: 352-61.
28. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, et al. Genome-wide orchestration of cardiac functions by orphan nucler receptors ERRα and γ. Cell Metab 2007; 5: 345-56.
29. Jeoung NH, Wu P, Joshi MA, Jaskiewicz J, Bock CB, Depaoli-Roach AA, et al. Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. Biochem J 2006; 397: 417-25.
30. Wende AR, Huss JM, Schaeffer PJ, Giguère V, Kelly DP. PGC-1α coactivates PDK4 gene expression via the orphan nuclear receptor ERRα: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005; 25: 10684-94.
31. Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F, et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006; 281: 39897-906.
32. Connaughton S, Chowdhury F, Attia RR, Song S, Zhang Y, Elam MB, et al. Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol 2010; 315: 159-67.
33. Cho Y, Hazen BC, Russell AP, Kralli A. Peroxisome proliferatoractivated receptor gamma coactivator 1 (PGC-1)-and estrogen-related receptor (ERR)-induced regulator in muscle 1 (Perm1) is a tissuespecific regulator of oxidative capacity in skeletal muscle cells. J Biol Chem 2013; 288: 25207-18.
34. Mirebeau-Prunier D, Le Pennec S, Jacques C, Fontaine JF, Gueguen N, Boutet-Bouzamondo N, et al. Estrogen-related receptor alpha modulates lactate dehydrogenase activity in thyroid tumors. PLoS One 2013; 8: e58683.
35. Summermatter S, Santos G, Perez-Schindler J, Handschin C. Skeletal muscle PGC-1alpha controls whole-body lactate homeostasis through estrogen-related receptor alpha-dependent activation of LDH B and repression of LDH A. Proc Natl Acad Sci USA 2013; 110: 8738-43.
36. Lee JH, Kim EJ, Kim DK, Lee JM, Park SB, Lee IK, et al. Hypoxia induces PDK4 gene expression through induction of the orphan nuclear receptor ERRgamma. PLoS One 2012; 7: e46324.
37. Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogenrelated receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 2008; 105: 7821-6.
38. Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, et al. ERRalpha augments HIF-1 signalling by directly interacting with HIF-1alpha in normoxic and hypoxic prostate cancer cells. J Pathol 2014; 233: 61-73.
39. Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 2013; 123: 3664-71.
40. Sladek R, Bader JA, Giguère V. The orphan nuclear receptor estrogenrelated receptor α is a transcriptional regulator of the human mediumchain acyl coenzyme A dehydrogenase gene. Mol Cell Biol 1997; 17: 5400-9.
41. Vega RB, Kelly DP. A role for estrogen-related receptor α in the control of mitochondrial fatty acid β-oxidation during brown adipocyte differentiation. J Biol Chem 1997; 272: 31693-9.
42. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006; 126: 789-99.
43. Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguère V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α. Mol Cell Biol 2003; 23: 7947-56.
44. Carrier JC, Deblois G, Champigny C, Levy E, Giguère V. Estrogen related-receptor α (ERRα) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J Biol Chem 2004; 279: 52052-8.
45. Ijichi N, Ikeda K, Horie-Inoue K, Yagi K, Okazaki Y, Inoue S. Estrogenrelated receptor alpha modulates the expression of adipogenesisrelated genes during adipocyte differentiation. Biochem Biophys Res Commun 2007; 358: 813-8.
46. Nie Y, Wong C. Suppressing the activity of ERRalpha in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal glucose uptake. J Cell Mol Med 2009; 13: 3051-60.
47. Ju D, He J, Zhao L, Zheng X, Yang G. Estrogen related receptor alphainduced adipogenesis is PGC-1beta-dependent. Mol Biol Rep 2012; 39: 3343-54.
48. Kubo M, Ijichi N, Ikeda K, Horie-Inoue K, Takeda S, Inoue S. Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation. Biochim Biophys Acta 2009; 1789: 71-7.
49. Alaynick WA, Kondo RP, Xie W, He W, Dufour CR, Downes M, et al. ERRγ directs and maintains the transition to oxidative metabolism in the post-natal heart. Cell Metab 2007; 6: 16-24.
50. Huss JM, Pineda Torra I, Staels B, Giguère V, Kelly DP. Estrogenrelated receptor α directs peroxisome proliferator-activated receptor α signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol 2004; 24: 9079-91.
51. Michalek RD, Gerriets VA, Nichols AG, Inoue M, Kazmin D, Chang CY, et al. Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci USA 2011; 108: 18348-53.
52. Narkar VA, Fan W, Downes M, Yu RT, Jonker JW, Alaynick WA, et al. Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ. Cell Metab 2011; 13: 283-93.
53. Sonoda J, Laganière J, Mehl IR, Barish GD, Chong LW, Li X, et al. Nuclear receptor ERRα and coactivator PGC-1β are effectors of IFN-γ induced host defense. Genes Dev 2007; 21: 1909-20.
54. Villena JA, Hock MB, Giguère V, Kralli A. Orphan nuclear receptor ERRα is essential for adaptive thermogenesis. Proc Natl Acad Sci USA 2007; 104: 1418-23.
55. Hong E-J, Levasseur M-P, Dufour CR, Perry M-C, Giguère V. Loss of estrogen-related receptor α promotes hepatocellular carcinogenesis development via metabolic and inflammatory disturbances. Proc Natl Acad Sci USA 2013; 110: 17975-80.
56. Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, et al. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. J Biol Chem 2010; 285: 22619-29.
57. Luo J, Sladek R, Bader J-A, Rossant J, Giguère V. Placental abnormalities in mouse embryos lacking orphan nuclear receptor ERRβ. Nature 1997; 388: 778-82.
58. Huss JM, Imahashi K-I, Dufour C, Weinheimer CJ, Courtois M, Kovacs A, et al. The nuclear receptor ERRα is required for the bioenergetic and functional adaption to cardiac pressure overload. Cell Metab 2007; 6: 25-37.
59. Foletta VC, Brown EL, Cho Y, Snow RJ, Kralli A, Russell AP. Ndrg2 is a PGC-1alpha/ERRalpha target gene that controls protein synthesis and expression of contractile-type genes in C2C12 myotubes. Biochim Biophys Acta 2013; 1833: 3112-23.
60. LaBarge S, McDonald M, Smith-Powell L, Auwerx J, Huss JM. Estrogen-related receptor-alpha (ERRalpha) deficiency in skeletal muscle impairs regeneration in response to injury. FASEB J 2014; 28: 1082-97.
61. Luo Y, Kumar P, Mendelson CR. Estrogen-related receptor gamma (ERRgamma) regulates oxygen-dependent expression of voltagegated potassium (K+) channels and tissue kallikrein during human trophoblast differentiation. Mol Endocrinol 2013; 27: 940-52.
62. Poidatz D, Dos Santos E, Brule A, De Mazancourt P, Dieudonne MN. Estrogen-related receptor gamma modulates energy metabolism target genes in human trophoblast. Placenta 2012; 33: 688-95.
63. Cauchy F, Fuks D, Zarzavadjian Le Bian A, Belghiti J, Costi R. Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol 2014; 6: 306-14.
64. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010; 375: 181-3.
65. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-7.
66. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-73.
67. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, et al. ERRα and GABPAα/β specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 2004; 101: 6570-5.
68. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466-71.
69. Pollak M. Potential applications for biguanides in oncology. J Clin Invest 2013; 123: 3693-700.
70. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, Kulkarni A, et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci USA 2007; 104: 16480-5.
71. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 2003; 100: 10207-12.
72. Herzog B, Cardenas J, Hall RK, Villena JA, Budge PJ, Giguère V, et al. Estrogen-related receptor α is a repressor of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 2006; 281: 99-106.
73. Patch RJ, Searle LL, Kim AJ, De D, Zhu X, Askari HB, et al. Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents. J Med Chem 2011; 54: 788-808.
74. Ranhotra HS. Up-regulation of orphan nuclear estrogen-related receptor α expression during long-term caloric restriction in mice. Mol Cell Biochem 2009: 59-65.
75. Kim DK, Ryu D, Koh M, Lee MW, Lim D, Kim MJ, et al. Orphan nuclear receptor estrogen-related receptor gamma (ERRgamma) is key regulator of hepatic gluconeogenesis. J Biol Chem 2012; 287: 21628-39.
76. Kim DK, Gang GT, Ryu D, Koh M, Kim YN, Kim SS, et al. Inverse agonist of nuclear receptor ERRgamma mediates antidiabetic effect through inhibition of hepatic gluconeogenesis. Diabetes 2013; 62: 3093-102.
77. Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014; 510: 84-91.
78. Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism 2014; 63: 895-902.
79. Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012; 52: 381-400.
80. Houde VP, Brule S, Festuccia WT, Blanchard PG, Bellmann K, Deshaies Y, et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes 2010; 59: 1338-48.
81. Levy G, Schmidli H, Punch J, Tuttle-Newhall E, Mayer D, Neuhaus P, et al. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12-and 36-month results. Liver Transpl 2006; 12: 1640-8.
82. Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C, et al. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol 2011; 55: 388-98.
83. Watt KD. Metabolic syndrome: is immunosuppression to blame? Liver Transpl 2011; 17 Suppl 3: S38-42.
84. Tremblay AM, Dufour CR, Ghahremani M, Reudelhuber TL, Giguère V. Physiological genomics identifies estrogen-related receptor α as a regulator of renal sodium and potassium homeostasis and the reninangiotensin pathway. Mol Endocrinol 2010; 24: 22-32.
85. Komm BS, Mirkin S. An overview of current and emerging SERMs. J Steroid Biochem Mol Biol 2014; 143C: 207-22.
86. Kim DK, Kim JR, Koh M, Kim YD, Lee JM, Chanda D, et al. Estrogenrelated receptor gamma (ERRgamma) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. J Biol Chem 2011; 286: 38035-42.
87. Franko A, von Kleist-Retzow JC, Neschen S, Wu M, Schommers P, Bose M, et al. Liver adapts mitochondrial function to insulin resistant and diabetic states in mice. J Hepatol 2014; 60: 816-23.
88. Jelenik T, Sequaris G, Kaul K, Ouwens DM, Phielix E, Kotzka J, et al. Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes. Diabetes 2014; 63: 3856-67.
89. Misu H, Takamura T, Matsuzawa N, Shimizu A, Ota T, Sakurai M, et al. Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes. Diabetologia 2007; 50: 268-77.
90. Razak F, Anand SS. Impaired mitochondrial activity in the insulinresistant offspring of patients with type 2 diabetes. Vasc Med 2004; 9: 223-4.
91. Pawlyk AC, Giacomini KM, McKeon C, Shuldiner AR, Florez JC. Metformin pharmacogenomics: current status and future directions. Diabetes 2014; 63: 2590-9.
92. Huppunen J, Wohlfahrt G, Aarnisalo P. Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma. Mol Cell Endocrinol 2004; 219: 151-60.
93. Murray J, Auwerx J, Huss JM. Impaired myogenesis in estrogenrelated receptor gamma (ERRgamma)-deficient skeletal myocytes due to oxidative stress. FASEB J 2013; 27: 135-50.
94. Chang CY, Kazmin D, Jasper JS, Kunder R, Zuercher WJ, McDonnell DP. The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell 2011; 20: 500-10.
95. Ariazi EA, Clark GM, Mertz JE. Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res 2002; 62: 6510-8.
96. Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res 2004; 64: 4670-6.